Vivo Capital, LLC Celldex Therapeutics, Inc. Transaction History

Vivo Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $8.16 Million - $13.5 Million	-359,653 Reduced 64.38%	198,983 $5.59 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $1.43 Million - $2.6 Million	-69,720 Reduced 11.1%	558,636 $15.1 Million
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $3.98 Million - $5.66 Million	143,903 Added 29.7%	628,356 $21.4 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $14 Million - $27.1 Million	-484,453 Reduced 50.0%	484,453 $26.2 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $6.69 Million - $11.4 Million	-322,969 Reduced 25.0%	968,906 $32.4 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $6.46 Million - $9.8 Million	-430,625 Reduced 25.0%	1,291,875 $22.6 Million
Q3 2020 Nov 13, 2020	BUY	$9.65 - $15.19 $1.18 Million - $1.86 Million	122,500 Added 7.66%	1,722,500 $25.5 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $2.58 Million - $21.5 Million	1,600,000 New	1,600,000 $20.8 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.